Clinical Trial Update: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating first-line treatment for advanced non-small-cell lung cancer without driver gene alterations; status not yet disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: UNKNOWN